Catalogue/Metabolic Research/Cagrilintide
Metabolic Research

Cagrilintide

Sold outStock quantity: 0
Request availability update
Reference presentationSynthetic peptide
Section 01

Product identity

Product name
Cagrilintide
Synonyms
AM833, long-acting amylin analogue
Research category
Metabolic Research
Compound type
Synthetic peptide
Section 02

Research intelligence

Research area

Metabolic

Molecule type

Synthetic peptide

Peptide length

32 amino acids

Documentation status

Not yet verified

Batch verification status

Not yet verified

Stock status

Sold out · quantity 0

Section 03

Reference chemical information

Reference chemical information is provided for compound identification only. The exact form, salt, counter-ion, hydration state and molecular mass of a supplied material must be confirmed against its batch-specific Certificate of Analysis and Safety Data Sheet.

Sequence length
32 amino acids
Reference molecular formula
Lipidated amylin-analogue peptide. Exact formula pending manufacturer confirmation of the supplied form.
Reference molecular weight
Approximately 3.8 kDa for the free peptide. Exact mass depends on supplied form. Pending confirmation.
Reference CAS number
1415456-99-3
Technical note

Exact molecular formula, molecular weight and salt form must be confirmed against manufacturer documentation before publication.

Section 04

Research context

Cagrilintide is a synthetic long-acting analogue of the peptide amylin. It is investigated in experimental metabolic research.

Section 05

Current product specification

Values below reflect the physical material available for release. Fields are populated only from manufacturer documentation, a batch-specific Certificate of Analysis, an independent laboratory report or a Safety Data Sheet. Until such documents are received and verified, fields remain marked Pending batch-specific documentation.

Stock status
Sold out
Stock quantity
0
Catalogue SKU
Pending batch-specific documentation
Actual supplied chemical form
Pending batch-specific documentation
Counter-ion or salt form
Pending batch-specific documentation
Nominal vial content
Pending batch-specific documentation
Supplier
Pending batch-specific documentation
Manufacturer
Pending batch-specific documentation
Country of manufacture
Pending batch-specific documentation
Batch number
Pending batch-specific documentation
Lot number
Pending batch-specific documentation
Purity result
Pending batch-specific documentation
Identity result
Pending batch-specific documentation
HPLC result
Pending batch-specific documentation
LC-MS result
Pending batch-specific documentation
Water content
Pending batch-specific documentation
Residual solvent result
Pending batch-specific documentation
Endotoxin result
Pending batch-specific documentation
Bioburden result
Pending batch-specific documentation
Sterility result
Pending batch-specific documentation
Manufacturing date
Pending batch-specific documentation
Retest or expiry date
Pending batch-specific documentation
Storage requirement
Pending batch-specific documentation
COA file
Not supplied
SDS file
Not supplied
Independent test report
Not supplied
Document verification status
Not yet verified
Section 06

Batch documentation

Certificate of Analysis
Not supplied
Safety Data Sheet
Not supplied
Independent test report
Not supplied
Document verification status
Not yet verified

Documents are linked to a specific chemical form, batch or lot number, document date, named testing laboratory and applicable vial stock. A generic Certificate of Analysis is never applied to future batches.

Section 07

Storage and handling

Storage requirement

Pending batch-specific documentation

Handling

Handle in accordance with the batch-specific Safety Data Sheet once issued. No reconstitution or administration instructions are provided.

Section 08

Regulatory and use restrictions

For laboratory research and analytical use only. Not intended for human or veterinary use, clinical use, diagnostic use, food use, cosmetic application or administration to humans or animals. No instructions concerning dosage, administration, reconstitution or therapeutic use are provided.
Section 09

References

  • Reference CAS: 1415456-99-3
  • Batch-specific documentation: Pending batch-specific documentation
Section 10

Scientific References

Reference links will become available as the catalogue expands.

PubChem — pending
PubMed — pending
UniProt — pending
Literature — pending
Section 11

Related compounds

Similar molecular families